• Cardiff Oncology held its annual shareholder meeting on June 11, 2026.
• Shareholders ratified BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors authorized an amendment to the 2021 Equity Incentive Plan, lifting the share pool to 15,150,000 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-267563), on June 11, 2026, and is solely responsible for the information contained therein.